98%
921
2 minutes
20
The inflammatory bowel diseases (IBDs) are systemic conditions that affect not only the gastrointestinal tract but also other parts of the body. The presence of extraintestinal manifestations can significantly impact the quality of life in IBD patients. Peripheral arthritis, episcleritis, and erythema nodosum are frequently associated with active intestinal inflammation and often improve with standard treatment targeting intestinal inflammation. In contrast, anterior uveitis, ankylosing spondylitis, and primary sclerosing cholangitis typically occur independently of disease flares. The incidence of these conditions in individuals with IBD can reach up to 50% of patients over the course of their lifetime. In addition, some advanced therapies utilized for the treatment of IBD potentially result in side effects that may resemble extraintestinal manifestations. This review provides a thorough analysis of the pathophysiology and treatment of extraintestinal manifestations associated with Crohn's disease and ulcerative colitis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11351332 | PMC |
http://dx.doi.org/10.3390/biomedicines12081839 | DOI Listing |
Introduction: Lower urinary tract symptoms are common in patients with inflammatory bowel disease; however, the association between ulcerative colitis and chronic prostatitis remains underrecognized.
Case Presentation: A 38-year-old man presented with frequent and painful urination unresponsive to the standard treatment of chronic prostatitis. He was subsequently diagnosed with ulcerative colitis based on persistent hematochezia and colonoscopy findings.
Rev Clin Esp (Barc)
September 2025
Departamento de enfermería, Hospital Universitario de Canarias, Tenerife, Spain. Electronic address:
Background: Non-celiac gluten sensitivity (NCGS) is characterized by a combination of intestinal and extra-intestinal symptoms triggered by gluten consumption, without evidence of celiac disease (CD) or wheat allergy (WA). Anemia, as an extra-intestinal manifestation, has been little studied in this context.
Main Objective: To synthesize the available evidence on the association between NCGS and anemia.
Clin Rheumatol
September 2025
Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Objectives: This study compared the incidence and time-to-event outcomes of ocular extraintestinal manifestations (O-EIMs) and EIMs among patients with human leukocyte antigen (HLA)-B27-associated diseases receiving different classes of immunotherapy.
Methods: A retrospective cohort study was conducted using aggregated electronic health records from the TriNetX network between January 1, 2014, and December 31, 2024. Patients with HLA-B27-associated diseases were included if they were newly prescribed tumor necrosis factor (TNF), janus kinase (JAK), or interleukin (IL) inhibitors on or after their initial diagnosis.
J Crohns Colitis
September 2025
Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Advanced combination treatment (ACT)-the combination of two advanced agents such as biologics or small molecules-has emerged as a promising strategy in the management of inflammatory bowel disease refractory to conventional treatment, with severe extraintestinal manifestations, or with coexisting immune-mediated inflammatory diseases. ACT including complementary mechanisms of action aims to overcome the therapeutic ceiling observed with monotherapy. Its rationale is supported by preclinical and mechanistic data demonstrating synergistic immunological effects when distinct inflammatory pathways are targeted simultaneously.
View Article and Find Full Text PDFLaryngoscope
September 2025
Department of Otolaryngology - Head and Neck Surgery, School of Medicine, Showa Medical University, Tokyo, Japan.
We report a rare case of a sterile nasal septal abscess (NSA) occurring as an extraintestinal manifestation of ulcerative colitis (UC), accompanied by a novel histopathologic finding. A 40-year-old woman with relapsed UC presented with nasal swelling, purulent discharge, hematochezia, and skin lesions. Computed tomography revealed an anterior NSA, and emergent endoscopic drainage was performed.
View Article and Find Full Text PDF